Vol 7, No 13 (July 15, 2019): Annals of Translational Medicine (Focus on “Pompe Disease”)

Original Article

Variable clinical features and genotype-phenotype correlations in 18 patients with late-onset Pompe disease
Jousef Alandy-dy, Marie Wencel, Kathy Hall, Julie Simon, Yanjun Chen, Erik Valenti, Jade Yang, Deeksha Bali, Anita Lakatos, Namita Goyal, Tahseen Mozaffar, Virginia Kimonis
Annals of Translational Medicine
 2019;
7
(13)
:276
Assessing metabolic profiles in human myoblasts from patients with late-onset Pompe disease
Peter Meinke, Sarah Limmer, Stefan Hintze, Benedikt Schoser
Annals of Translational Medicine
 2019;
7
(13)
:277

Review Article

Molecular genetics of Pompe disease: a comprehensive overview
Paolo Peruzzo, Eleonora Pavan, Andrea Dardis
Annals of Translational Medicine
 2019;
7
(13)
:278
Pros and cons of different ways to address dysfunctional autophagy in Pompe disease
Jeong-A Lim, Naresh Kumar Meena, Nina Raben
Annals of Translational Medicine
 2019;
7
(13)
:279
Restoring the regenerative balance in neuromuscular disorders: satellite cell activation as therapeutic target in Pompe disease
Gerben J. Schaaf, Rodrigo Canibano-Fraile, Tom J. M. van Gestel, Ans T. van der Ploeg, W. W. M. Pim Pijnappel
Annals of Translational Medicine
 2019;
7
(13)
:280
Newborn screening: Taiwanese experience
Yin-Hsiu Chien, Wuh-Liang Hwu, Ni-Chung Lee
Annals of Translational Medicine
 2019;
7
(13)
:281
Nutrition and exercise in Pompe disease
Mark A. Tarnopolsky, Mats I. Nilsson
Annals of Translational Medicine
 2019;
7
(13)
:282
Long-term outcome and unmet needs in infantile-onset Pompe disease
Andreas Hahn, Anne Schänzer
Annals of Translational Medicine
 2019;
7
(13)
:283
Multisystem late onset Pompe disease (LOPD): an update on clinical aspects
Antonio Toscano, Carmelo Rodolico, Olimpia Musumeci
Annals of Translational Medicine
 2019;
7
(13)
:284
Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review
Ankit K. Desai, Cindy Li, Amy S. Rosenberg, Priya S. Kishnani
Annals of Translational Medicine
 2019;
7
(13)
:285
Diagnostic tools in late onset Pompe disease (LOPD)
Olimpia Musumeci, Antonio Toscano
Annals of Translational Medicine
 2019;
7
(13)
:286
Progress and challenges of gene therapy for Pompe disease
Giuseppe Ronzitti, Fanny Collaud, Pascal Laforet, Federico Mingozzi
Annals of Translational Medicine
 2019;
7
(13)
:287
Liver depot gene therapy for Pompe disease
Priya S. Kishnani, Dwight D. Koeberl
Annals of Translational Medicine
 2019;
7
(13)
:288
An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond
Aditi Korlimarla, Jeong-A Lim, Priya S. Kishnani, Baodong Sun
Annals of Translational Medicine
 2019;
7
(13)
:289
Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy
Barry J. Byrne, David D. Fuller, Barbara K. Smith, Nathalie Clement, Kirsten Coleman, Brian Cleaver, Lauren Vaught, Darin J. Falk, Angela McCall, Manuela Corti
Annals of Translational Medicine
 2019;
7
(13)
:290
Challenges in treating Pompe disease: an industry perspective
Hung V. Do, Richie Khanna, Russell Gotschall
Annals of Translational Medicine
 2019;
7
(13)
:291
Pompe disease: what are we missing?
Benedikt Schoser
Annals of Translational Medicine
 2019;
7
(13)
:292
The role of patient advocacy organizations in shaping medical research: the Pompe model
Tiffany House, Kevin O’Donnell, Raymond Saich, Fabio Di Pietro, Ria Broekgaarden, Allan Muir, Thomas Schaller
Annals of Translational Medicine
 2019;
7
(13)
:293

Disclosure:

The focused issue “Pompe Disease” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Rosa Puertollano and Nina Raben served as the unpaid Guest Editors for the focused issue.